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Abstract
Cyclin D1 is an allosteric regulator for cyclin-dependent kinases 4 and 6 (CDK4/6). The cyclin D/
CDK4 kinase promotes G1/S transition through the posttranslational modification and the
subsequent inactivation of the retinoblastoma (Rb) protein and related family members (p107 and
p130). Accumulation of cyclin D1 is tightly regulated through various mechanisms including
transcription, protein localization and ubiquitin-dependent proteolysis. While regulators of cyclin
D1 gene expression have been under considerable scrutiny, the identity of the protein complex
that targets cyclin D1 protein for degradation, the putative E3 ubiquitin ligase, has remained
obscure. In a recent report, Lin et al [1] describe the identification and characterization of a novel
SCF, wherein FBX4 and αB-crystallin serve as specificity factors that direct ubiquitination of
phosphorylated cyclin D1. As cyclin D1 overexpression in human cancer has been postulated to
occur through the loss of degradation machinery, the identification of the SCFFbx4/αB-crystallin ligase
will allow new experimental approaches that address mechanisms of cyclin D1 overexpression in
human cancer.
Background
Protein ubiquitination: quick overview
Ubiquitin is a polypeptide comprised of 76 amino acids
that can be covalently attached to substrates through an
enzymatic cascade that includes three enzymes: E1, E2
and E3. E1, the ubiquitin-activating enzyme, utilizes the
energy of ATP to activate ubiquitin and passes ubiquitin
to the ubiquitin-conjugating enzyme, E2. The E2 together
with the E3, or ubiquitin ligase, attaches ubiquitin mole-
cules to target proteins.
The E3 is the most diverse and drives substrate-specific
interactions. There are two essential E3 ligases that per-
form the ubiquitination of proteins in the cell cycle: the
SCF (Skp1/Cul1/F-box protein) ligases and the anaphase-
promoting complex/cyclosome, or APC/C. In general,
SCF ligases regulate G1 to S-phase transitions, while the
APC/C regulates G2/M. For the SCF ligase, the F-box pro-
teins act as substrate-specific receptors while the remain-
ing components of the ligase (Skp1/Cul1/Rbx1) are
common for various substrates. There are at least 70 F-box
proteins in mammals [2], which can be further classified
into three sub-groups based on their substrate recognition
motifs: FBL (Leucine-rich motifs), FBW (WD40 repeats)
and FBX (F-box only), in which the substrate-binding
motif has not been identified yet.
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Discussion
SCFFbx4/αB-crystallin complex: the identity uncovered
As with most cyclins, early studies revealed that cyclin D1
is a highly labile protein and this lability is dependent
upon the ubiquitin-dependent proteolysis [3,4]. Criti-
cally, the ubiquitination and degradation of cyclin D1
required phosphorylation of a single residue, threonine-
286 (T286). In addition to regulating ubiquitin-mediated
destruction, further analysis revealed that phosphoryla-
tion of T286 was required for nuclear export of cyclin D1
during S-phase [5]. While the notion of phosphorylation-
dependent degradation might have been anticipated, the
revelation that degradation was coupled with nuclear
export provided an additional layer of control and com-
plexity. Taken together, the data imply that cyclin D1 is
regulated by a cytoplasmic SCF type ligase, given that the
SCF ligases typically target phosphorylated substrates.
While such a two-step system would ensure that cyclin D1
proteolysis is highly restricted, at the same time loss of
either event, nuclear export or phosphorylation, would
likely lead to overexpression of the cyclin D1 through the
inhibition of ubiquitination.
In order to identify the putative E3 ligase, cyclin D1 com-
plexes were affinity purified under conditions of proteas-
ome inhibition, in order to stabilize otherwise labile
interactions. Through this approach αB-crystallin was
identified as a protein that bound exclusively to the wild-
type cyclin D1 but not to non-phosphorylatable mutants.
αB-crystallin is more widely known as a member of the
small heat shock protein family, which primarily function
as molecular chaperones [6]. Of note, αB-crystallin was
previously identified as a binding partner for the F-box
only protein 4, Fbx4, where it promoted Fbx4-dependent
ubiquitination of unknown cellular substrates [7].
The identification of αB-crystallin as a proteasome and
phosphorylation-dependent binding partner for cyclin
D1 along with the putative role for αB-crystallin in the
regulation of protein ubiquitination provided sufficient
impetus for a hypothesis wherein αB-crystallin functions
in concert with Fbx4 to regulate cyclin D1 ubiquitination.
Consistent with this hypothesis, both Fbx4 and αB-crys-
tallin associated with cyclin D1 in vivo. The evidence that
both Fbx4 and αB-crystallin were required for the associa-
tion of a bona fide SCF complex with phosphorylated cyc-
lin D1 (p-D1) in vitro and in vivo strengthened the notion
that both Fbx4 and αB-crystallin functioned in substrate
recognition. Further support for such a model derives
from in vitro ubiquitination assays wherein both Fbx4 and
αB-crystallin were essential for the cyclin D1 ubiquitina-
tion. Likewise, knockdown of either Fbx4 or αB-crystallin
in cells reduced cyclin D1 ubiquitination and reduced cyc-
lin D1 proteolytic turnover resulting in accelerated cell
cycle progression. These data indicate that the SCFFbx4/αB-
crystallin ligase indeed regulates cyclin D1 turnover during
cell cycle and promotes cyclin D1 degradation at the G1/
S transition.
Biochemistry of SCFFbx4/αB-crystallin ligase: first insights
Two aspects of the SCFFbx4/αB-crystallin ligase make it unique
relative to a majority of the SCF ligases. The first aspect
pertains to Fbx4 itself; because Fbx4 lacks recognizable
protein-protein interaction motifs in its C-terminus, it is
unclear how it recognizes phosphorylated cyclin D1. This
characteristic likely contributes to the second unique
aspect of this ligase, that SCFFbx4/αB-crystallin is only the sec-
ond ligase wherein substrate recognition requires a co-fac-
tor in addition to the F-box component. The other
example is Skp2, which requires Cks1 for efficient recog-
nition and ubiquitination of p27Kip1. Here, Cks1 binds
specifically to the threonine-187 phosphorylated
p27Kip1and subsequently recruits Skp2 as well as core SCF
components [8]. Cks1 itself binds the C-terminus of Skp2
and induces structural changes in the distant N-terminal
region of Skp2 which in turn contribute to substrate bind-
ing [9]. With respect to the substrate, Cks1 binds directly
to Thr-187 phosphorylated p27Kip1 [10]. These two events
bring p-p27Kip1and SCF complex together and result in the
productive ubiquitination. The discovery of two ligases,
SCFSkp2/Cks1 and SCFFbx4/αB-crystallin, emphasizes the role of
the new regulatory element in the functionality of SCF
ligases. Thus, the activity of SCF complexes is regulated
not only at the level of the substrate phosphorylation, but
also involves novel accessory factors which fine-tune SCF
activities.
How does Fbx4 and αB-crystallin cooperate to target
phosphorylated cyclin D1? One can imagine three distinct
scenarios. In the first αB-crystallin binds directly to phos-
pho-Thr-286 and thereby serves as a bridge between cyclin
D1 and Fbx4 (Figure 1A). A second possibility is that Fbx4
and αB-crystallin both participate in the binding and rec-
ognition of phosphorylated cyclin D1. In this model, αB-
crystallin and Fbx4 cooperatively bind p-D1 (Figure 1B).
Such a model is analogous to Skp2/Cks1 recognition of p-
p27. Structural analysis of the latter complex revealed that
Cks1 provides a majority of the physical contacts with p-
27, with Skp2 providing minor additional physical con-
tacts [10]. Finally, in a third scenario, αB-crystallin bind-
ing might enforce a conformation change to Fbx4 that
then permits the recognition of phosphorylated cyclin D1
(Figure 1C). Existing biochemical evidence cannot rule
out any of the proposed models and additional experi-
ments are needed to establish the mechanism by which
SCFFbx4/αB-crystallin ligase recognizes cyclin D1.
In addition to cyclin D1, recent work has also identified
Pin2/TRF1 as a substrate for Fbx4-dependent ubiquitina-
tion [11]. Pin2/TRF1 is a telomere-binding protein thatCell Division 2007, 2:2 http://www.celldiv.com/content/2/1/2
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negatively regulates telomere length [12]. Pin2/TRF1 lev-
els are downregulated in various tumors and its ubiquitin
ligase is proposed to play a role in the deregulation of its
expression. Interestingly, the binding and ubiquitination
of Pin2/TRF1 occurs independently of αB-crystallin and
Pin2/TRF1 phosphorylation status. These results raise
intriguing issues such as, if αB-crystallin is not utilized for
Pin2/TRF1 recognition, is there a yet unidentified co-fac-
tor for recognition of Pin2/TRF1? If not, does Fbx4
directly bind a subset of substrates in a phosphorylation-
independent manner? Finally, Fbx4 apparently undergoes
alternative splicing resulting in an Fbx4 isoform with a
truncated C-terminus [13] (discussed later). One might
expect such an event to directly impact substrate selectiv-
ity. The identification of the additional SCFFbx4 targets
should provide insight with regard to the precise function
of co-factors, such as αB-crystallin, that function coopera-
tively with the SCFFbx4 complex to direct substrate recogni-
tion.
Cyclin D1 overexpression in cancer: does SCFFbx4/αB-crystallin 
play a role?
An important issue raised in this new work is whether an
altered functionality of cyclin D1 ubiquitin ligase can lead
to increased cyclin D1 expression and ultimately to the
tumorigenesis. Cyclin D1 overexpression occurs fre-
quently in human cancers, including lymphomas, breast
and esophageal carcinomas [14,15]. Gene amplification is
responsible for only 15% of cases of cyclin D1 overexpres-
sion in breast cancer [16]. Numerous studies have sug-
gested that defective cyclin D1 proteolysis may contribute
to its overexpression and thereby contribute to neoplastic
growth in the remaining cases [14,17,18]. In support of
this notion, αB-crystallin expression is lost in several
Possible roles of αB-crystallin in SCFFbx4-Cyclin D1 complex assembly Figure 1
Possible roles of αB-crystallin in SCFFbx4-Cyclin D1 complex assembly. A. αB-crystallin serves as a bridge between 
SCFFbx4 and Cyclin D1. B. αB-crystallin and Fbx 4 cooperatively bind Cyclin D1. C. The binding of αB-crystallin induces confor-
mational change in Fbx4 that provides the structural basis for the complex formation.Cell Division 2007, 2:2 http://www.celldiv.com/content/2/1/2
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breast cancer cell lines and this loss correlates with
decreased cyclin D1 proteolysis [19,20]. In MCF7, BT474
and MDA-MB-231 αB-crystallin is undetectable and loss
of αB-crystallin correlates with decreased cyclin D1 prote-
olysis. Expression of αB-crystallin and Fbx4 were also
assessed in primary esophageal cancers where cyclin D1 is
known be overexpressed in nearly 40% of cases [21].
Strikingly, approximately 20% of esophageal carcinomas
exhibited loss of either αB crystallin or Fbx4 as deter-
mined by immunohistochemistry. Additional screens and
in vivo models are needed to establish the role of this
ligase in cyclin D1 overexpression in tumors.
Deregulation of SCF components in cancer is not
restricted to Fbx4. Skp2 overexpression is detected in a
variety of cancer cell lines, as well as human tumors, such
as breast [22], prostate [23] and esophageal carcinomas
[24]. Increased Skp2 levels in these tumors often correlate
with the decrease in p27Kip1 levels. Another F-box protein,
Fbw7, targets cyclin E, Notch, c-Myc and c-Jun for protea-
some-dependent protein degradation and subsequently
the loss of Fbw7 contributes to tumorigenesis [25].
Regulation of F-box proteins through alternative splicing
Recent studies have revealed an additional layer of regula-
tion of the SCF ligases wherein certain F-box proteins are
subject to alternative splicing. Skp2 is one such F-box pro-
tein. Alternative splicing creates a C-terminally truncated
isoform, Skp2B. The two respective isoforms localize to
different cellular compartments: Skp2B resides in the
cytoplasm and Skp2 in the nucleus [26]. Structural studies
revealed that unstructured C-terminus of Skp2 directly
participates in the binding to Cks1 [10] and therefore, it is
likely that Skp2B is defective in Cks1 binding. It is of inter-
est to note that the two isoforms of Skp2 are differentially
expressed in breast cancer [26] perhaps suggesting selec-
tion for specific Skp2 activities. In addition to Skp2, Fbw7
has three alternative splice isoforms that utilize distinct
first exons and differ in their extreme N-termini [27].
Intriguingly, N-terminus of Fbw7 promotes homo- or het-
erodimerization and N-terminal mutants of Fbw7 are
defective in cyclin E turnover.
Analogous to Skp2 and Fbw7, Fbx4 is also subject to alter-
native splicing that gives rise to two isoforms, with iso-
form 2 being the C-terminal truncation of isoform 1. The
significance of the two isoforms in the regulation of sub-
strate ubiquitination is unclear. One might suggest that
two isoforms localize to different cellular compartments
where they orchestrate the turnover of target proteins.
Phosphorylation of cyclin D1 at T286 triggers CRM1-
dependent nuclear export of protein to the cytoplasm,
where its recognized and degraded by SCFFbx4/αB-crystallin
ligase. It is not surprising that Fbx4 localizes to the cyto-
plasm, however the study did not rule out the possibility
that the small fraction of Fbx4/αB-crystallin undergoes
nucleocytoplasmic trafficking. In the present study,
immunofluorescence localization experiments were per-
formed using two Fbx4 antibodies generated against
either N- or C-terminus of the protein and therefore
addressed the localization of both isoforms. In contrast,
another Fbx4 target, Pin2/TRF1 protein, is localized in the
nucleus where its levels drop at the G1/S boundary [28].
Fbx4 has been suggested to regulate the pool of Pin2/
TRF1that has been released from telomeres and therefore
that still might represent a cytoplasmic event. Addition-
ally, phosphorylation of αB-crystallin has been shown to
induce the accumulation of Fbx4 in nuclear speckles[29].
Further investigation of the role of C-terminus of Fbx4 in
the functionality of the ligase, substrate recognition as
well as Fbx4 localization will help to establish the signifi-
cance of two isoforms in the regulation of degradation of
substrates.
Concluding remarks
The identification of the SCFFbx4/αB-crystallin ligase sheds
new light on the regulation of cyclin D1 accumulation
and will permit a better analysis of the mechanisms that
contribute to cyclin D1 overexpression in cancer. Based
on the current evidence it is tempting to hypothesize that
an attenuation of the ligase function will lead to cyclin D1
overexpression, increased proliferation and, possibly,
tumorigenesis. The development of in vivo models that
target SCFFbx4/αB-crystallin activity, together with screening of
human tumors for loss of expression/mutations of either
Fbx4 or αB-crystallin are needed to critically address
whether the loss of SCFFbx4/αB-crystallin ligase function is
indeed an oncogenic event.
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